Literature DB >> 20479283

CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis.

M Gabriele Bixel1, Hang Li, Bjoern Petri, Alexander G Khandoga, Andrej Khandoga, Alexander Zarbock, Karen Wolburg-Buchholz, Hartwig Wolburg, Lydia Sorokin, Dagmar Zeuschner, Sigrid Maerz, Stefan Butz, Fritz Krombach, Dietmar Vestweber.   

Abstract

Leukocyte extravasation depends on various adhesion receptors at endothelial cell contacts. Here we have analyzed how mouse CD99 and CD99L2 cooperate with PECAM-1. We found that antibodies against mouse CD99 and PECAM-1 trap neutrophils between endothelial cells in in vitro transmigration assays. A sequential function, as has been suggested for human PECAM-1 and CD99, could not be demonstrated. In contrast to these in vitro results, blocking CD99 or CD99L2 or gene disruption of PECAM-1 trapped neutrophils in vivo between endothelial cells and the underlying basement membrane as revealed by electron microscopy and by 3-dimensional confocal fluorescence microscopy in the inflamed cremaster tissue. Leukocyte extravasation was inhibited in interleukin-1beta-inflamed peritoneum and in the cremaster by PECAM-1 gene disruption and was further attenuated by blocking antibodies against CD99 and CD99L2. In addition, CD99 and CD99L2 were required for leukocyte extravasation in the cremaster after stimulation with tumor necrosis factor-alpha, where the need for PECAM-1 is known to be bypassed. We conclude that CD99 and CD99L2 act independently of PECAM-1 in leukocyte extravasation and cooperate in an independent way to help neutrophils overcome the endothelial basement membrane.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479283     DOI: 10.1182/blood-2009-12-256388

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

Review 1.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

Review 2.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

Review 3.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

Review 4.  Endothelial membrane reorganization during leukocyte extravasation.

Authors:  Natalia Reglero-Real; Beatriz Marcos-Ramiro; Jaime Millán
Journal:  Cell Mol Life Sci       Date:  2012-05-10       Impact factor: 9.261

5.  Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability.

Authors:  Dörte Schulte; Verena Küppers; Nina Dartsch; Andre Broermann; Hang Li; Alexander Zarbock; Olena Kamenyeva; Friedemann Kiefer; Alexander Khandoga; Steffen Massberg; Dietmar Vestweber
Journal:  EMBO J       Date:  2011-08-19       Impact factor: 11.598

Review 6.  The regulation of transendothelial migration: new knowledge and new questions.

Authors:  William A Muller
Journal:  Cardiovasc Res       Date:  2015-05-17       Impact factor: 10.787

7.  Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling.

Authors:  Jan Rossaint; Oliver Spelten; Nadja Kässens; Helena Mueller; Hugo K Van Aken; Kai Singbartl; Alexander Zarbock
Journal:  Kidney Int       Date:  2011-05-11       Impact factor: 10.612

8.  How endothelial cells regulate transmigration of leukocytes in the inflammatory response.

Authors:  William A Muller
Journal:  Am J Pathol       Date:  2014-04       Impact factor: 4.307

Review 9.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

10.  A composite model of the human postcapillary venule for investigation of microvascular leukocyte recruitment.

Authors:  Holly M Lauridsen; Jordan S Pober; Anjelica L Gonzalez
Journal:  FASEB J       Date:  2013-12-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.